Comparison of eBX and Mohs Surgery for Treatment of Early-stage Non-melanoma Skin Cancer a Matched Pair Cohort Study.

Completed

Conditions studied: Nonmelanoma Skin Cancer

In brief

This is a retrospective-prospective study design. Patients who completed treatment approximately 3 years (range of 2-4 years) at time of IRB approval of this study will be identified and any existing data in the patient's record will be collected in addition to conducting office visits for long-term follow-up.

Key facts

Study ID

NCT03024866

Run by

Xoft, Inc.

People needed

369

Starts

2016-10-01

Expected to finish

2017-03-01

Last updated by the study team

2025-02-06

Who can join

Age: 41 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Previously completed treatment for non-melanoma skin cancer using Xoft eBx Electronic Brachytherapy System or Mohs surgery;
• Provides informed Consent;
• Greater than 40 years of age;
• Pathological diagnosis confirmed to be squamous cell or basal cell carcinoma prior to treatment;
• Cancer Staging included in this study:
• Stage 0: Tis, N0, M0
• Stage 1: T1, N0, M0
• Stage 2: T2, N0, M0 and ≤ 4cm in diameter

You may not qualify if…

• Target area is adjacent to a burn scar
• Any prior definitive surgical resection of the cancer, prior to Radiation Treatment
• Known perineural invasion
• Actinic Keratosis
• Known spread to regional lymph nodes
• Known metastatic disease

Where it is running

• Kenneth A. Miller, PC — Los Gatos, California, United States
• Dermatology & Laser Center of San Diego — San Diego, California, United States
• Dermatology and Laser Center of San Diego — San Diego, California, United States
• Strimling Laser and Vein Institute — Las Vegas, Nevada, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.